ARCHIVES

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

Nancy Brinker Resigns As CEO of Komen

August 10, 2012